Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development.
about
Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.Oral bioavailability enhancement through supersaturation: an update and meta-analysis.Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain.Development of a continuous dissolution/absorption system--a technical note.Effect of excipients on the particle size of precipitated pioglitazone in the gastrointestinal tract: impact on bioequivalence.The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCBiopharmaceutical modeling of drug supersaturation during lipid-based formulation digestion considering an absorption sink.Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement.
P2860
Q35794501-70A5673A-D7C9-4867-9472-F582026AD44AQ38119168-559D2C06-77DF-4715-96C7-1A909313D25CQ38917369-B937B315-273E-4802-87FD-9577FBBE6A4EQ40665162-C6E91954-2BF3-4BBF-BF76-3B0245E5B57CQ41854431-87831A6F-5A0F-42FA-87AA-B871D2302EE8Q41948304-73CBA594-4B65-4EA3-8E2A-B08AC9DD6AFCQ41948835-17E8B4D0-7B03-4318-9702-ECE5134AB3B0Q43442310-8A46E879-ACEA-4C29-9D2A-247F836A449DQ47141833-DC5DAAEE-6B8F-4D7C-8028-B02CE1F71E80
P2860
Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Application of dissolution/per ...... ble drugs in drug development.
@en
Application of dissolution/per ...... ble drugs in drug development.
@nl
type
label
Application of dissolution/per ...... ble drugs in drug development.
@en
Application of dissolution/per ...... ble drugs in drug development.
@nl
prefLabel
Application of dissolution/per ...... ble drugs in drug development.
@en
Application of dissolution/per ...... ble drugs in drug development.
@nl
P2093
P2860
P1476
Application of dissolution/per ...... ble drugs in drug development.
@en
P2093
Claudia da Costa Mathews
Jing Wen Wong
Kelly Lane Jones
Kiyohiko Sugano
Makoto Kataoka
Shinji Sakuma
Shinji Yamashita
Yoshie Masaoka
P2860
P304
P356
10.1007/S11095-011-0623-2
P577
2011-12-02T00:00:00Z